Fiduciary Trust’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
35,087
+302
+0.9% +$9.59K 0.01% 418
2026
Q1
$1.1M Buy
34,785
+1,580
+5% +$49.8K 0.01% 398
2025
Q4
$978K Sell
33,205
-43
-0.1% -$1.2K 0.01% 418
2025
Q3
$840K Buy
33,248
+116
+0.4% +$2.83K 0.01% 447
2025
Q2
$795K Buy
33,132
+182
+0.6% +$4.22K 0.01% 453
2025
Q1
$755K Buy
32,950
+2,233
+7% +$53.9K 0.01% 454
2024
Q4
$778K Buy
30,717
+6,645
+28% +$168K 0.01% 405
2024
Q3
$600K Buy
24,072
+1,070
+5% +$31.7K 0.01% 449
2024
Q2
$682K Buy
23,002
+4,626
+25% +$128K 0.01% 401
2024
Q1
$554K Buy
+18,376
New +$510K 0.01% 439

Other funds holding RTO

Fiduciary Trust's RTO Position: Q2 2026 in Review

Fiduciary Trust increased its Rentokil (RTO) stake by 0.87% in Q2 2026, buying an estimated $9.59K and bringing the position to 35,087 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #418.

Fiduciary Trust first reported a position in RTO in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.1M in Q1 2026. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Fiduciary Trust held 35,087 shares of Rentokil worth $1M as of Q2 2026.
  • Fiduciary Trust bought 302 Rentokil shares in Q2 2026, an estimated $9.59K.
  • Rentokil made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #418 holding.
  • Fiduciary Trust first reported a position in Rentokil in Q1 2024 and has held it in 10 quarters since.
  • Fiduciary Trust's Rentokil position peaked at $1.1M in Q1 2026.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.